Daniel N Meijles

9PUBLICATIONS
28CO-AUTHORS
Toxicology (incl. clinical toxicology)Structure and dynamics of materialsCardiology (incl. cardiovascular diseases)Molecular targetsMicro-manipulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 08, 2024
Striatin plays a major role in angiotensin II-induced cardiomyocyte and cardiac hypertrophy in mice in vivo.

Joshua J Cull, Susanna T E Cooper, Hajed O Alharbi

|Oct 07, 2022
Vascular Collagen Type-IV in Hypertension and Cerebral Small Vessel Disease.

Apoorva A Kumar, Natalie Yeo, Max Whittaker

|Jul 27, 2022
Of Mouse and Man: Cross-Species Characterization of Hypertensive Cardiac Remodeling.

Susanna T E Cooper, Joseph D Westaby, Zoe H R Haines

|Jun 22, 2022
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses.

Jacqueline J T Marshall, Joshua J Cull, Hajed O Alharbi

|Feb 11, 2022
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.

Angela Clerk, Daniel N Meijles, Michelle A Hardyman

|Jul 23, 2021
The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension.

Daniel N Meijles, Joshua J Cull, Susanna T E Cooper

Pageof 2